![](/img/cover-not-exists.png)
PUK1 INCIDENCE AND COST OF ADVERSE EVENTS (AES) IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) TREATED WITH ANGIOGENESIS INHIBITORS (AIS)
E Dial, MS Duh, L Antras, D Rodermund, MP Neary, TK Choueiri, WK OhVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72356-1
File:
PDF, 77 KB
english, 2010